Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Shalaka S. Hampras; Lara E. Sucheston-Campbell; Rikki Cannioto; Jenny Chang-Claude; Francesmary Modugno; Thilo Doerk; Peter Hillemanns; Leah Preus; Keith L. Knutson; Paul K. Wallace; Chi-Chen Hong; Grace Friel; Warren Davis; Mary Nesline; Celeste L. Pearce; Linda E. Kelemen; Marc T. Goodman; Elisa V. Bandera; Kathryn L. Terry; Nils Schoof; Kevin H. Eng; Alyssa Clay; Prashant K. Singh; Janine M. Joseph; Katja K. H. Aben; Hoda Anton-Culver; Natalia Antonenkova; Helen Baker; Yukie Bean; Matthias W. Beckmann; Maria Bisogna; Line Bjorge; Natalia Bogdanova; Louise A. Brinton; Angela Brooks-Wilson; Fiona Bruinsma; Ralf Butzow; Ian G. Campbell; Karen Carty; Linda S. Cook; Daniel W. Cramer; Cezary Cybulski; Agnieszka Dansonka-Mieszkowska; Joe Dennis; Evelyn Despierre; Ed Dicks; Jennifer A. Doherty; Arto Leminen; Heli Nevanlinna; Liisa M. Pelttari; Australian Ovarian Canc Study Grp

doi:10.18632/oncotarget.10215

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

Shalaka S. Hampras, Lara E. Sucheston-Campbell, Rikki Cannioto, Jenny Chang-Claude, Francesmary Modugno, Thilo Doerk, Peter Hillemanns, Leah Preus, Keith L. Knutson, Paul K. Wallace, Chi-Chen Hong, Grace Friel, Warren Davis, Mary Nesline, Celeste L. Pearce, Linda E. Kelemen, Marc T. Goodman, Elisa V. Bandera, Kathryn L. Terry, Nils SchoofKevin H. Eng, Alyssa Clay, Prashant K. Singh, Janine M. Joseph, Katja K. H. Aben, Hoda Anton-Culver, Natalia Antonenkova, Helen Baker, Yukie Bean, Matthias W. Beckmann, Maria Bisogna, Line Bjorge, Natalia Bogdanova, Louise A. Brinton, Angela Brooks-Wilson, Fiona Bruinsma, Ralf Butzow, Ian G. Campbell, Karen Carty, Linda S. Cook, Daniel W. Cramer, Cezary Cybulski, Agnieszka Dansonka-Mieszkowska, Joe Dennis, Evelyn Despierre, Ed Dicks, Jennifer A. Doherty, Arto Leminen, Heli Nevanlinna, Liisa M. Pelttari, Australian Ovarian Canc Study Grp

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Oncotarget
Volume	7
Issue number	43
Pages (from-to)	69097-69110
Number of pages	14
ISSN	1949-2553
DOIs	https://doi.org/10.18632/oncotarget.10215
Publication status	Published - 25 Oct 2016
MoE publication type	A1 Journal article-refereed

Fields of Science

ovarian cancer
immunosuppression
biomarkers
genetic variation
TGFBR2
REGULATORY T-CELLS
FC-GAMMA-RIIB
PERIPHERAL-BLOOD
BREAST-CANCER
DENDRITIC CELLS
LUNG-CANCER
RECEPTOR
STAGE
EXPRESSION
CARCINOMA
3122 Cancers
3123 Gynaecology and paediatrics

Access to Document

10.18632/oncotarget.10215

Cite this

Hampras, S. S., Sucheston-Campbell, L. E., Cannioto, R., Chang-Claude, J., Modugno, F., Doerk, T., Hillemanns, P., Preus, L., Knutson, K. L., Wallace, P. K., Hong, C.-C., Friel, G., Davis, W., Nesline, M., Pearce, C. L., Kelemen, L. E., Goodman, M. T., Bandera, E. V., Terry, K. L., ... Australian Ovarian Canc Study Grp (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget, 7(43), 69097-69110. https://doi.org/10.18632/oncotarget.10215

@article{3832f6c40ec94292b1ef494c227db078,

title = "Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer",

keywords = "ovarian cancer, immunosuppression, biomarkers, genetic variation, TGFBR2, REGULATORY T-CELLS, FC-GAMMA-RIIB, PERIPHERAL-BLOOD, BREAST-CANCER, DENDRITIC CELLS, LUNG-CANCER, RECEPTOR, STAGE, EXPRESSION, CARCINOMA, 3122 Cancers, 3123 Gynaecology and paediatrics",

author = "Hampras, {Shalaka S.} and Sucheston-Campbell, {Lara E.} and Rikki Cannioto and Jenny Chang-Claude and Francesmary Modugno and Thilo Doerk and Peter Hillemanns and Leah Preus and Knutson, {Keith L.} and Wallace, {Paul K.} and Chi-Chen Hong and Grace Friel and Warren Davis and Mary Nesline and Pearce, {Celeste L.} and Kelemen, {Linda E.} and Goodman, {Marc T.} and Bandera, {Elisa V.} and Terry, {Kathryn L.} and Nils Schoof and Eng, {Kevin H.} and Alyssa Clay and Singh, {Prashant K.} and Joseph, {Janine M.} and Aben, {Katja K. H.} and Hoda Anton-Culver and Natalia Antonenkova and Helen Baker and Yukie Bean and Beckmann, {Matthias W.} and Maria Bisogna and Line Bjorge and Natalia Bogdanova and Brinton, {Louise A.} and Angela Brooks-Wilson and Fiona Bruinsma and Ralf Butzow and Campbell, {Ian G.} and Karen Carty and Cook, {Linda S.} and Cramer, {Daniel W.} and Cezary Cybulski and Agnieszka Dansonka-Mieszkowska and Joe Dennis and Evelyn Despierre and Ed Dicks and Doherty, {Jennifer A.} and Arto Leminen and Heli Nevanlinna and Pelttari, {Liisa M.} and {Australian Ovarian Canc Study Grp}",

year = "2016",

month = oct,

day = "25",

doi = "10.18632/oncotarget.10215",

language = "English",

volume = "7",

pages = "69097--69110",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "43",

}

Hampras, SS, Sucheston-Campbell, LE, Cannioto, R, Chang-Claude, J, Modugno, F, Doerk, T, Hillemanns, P, Preus, L, Knutson, KL, Wallace, PK, Hong, C-C, Friel, G, Davis, W, Nesline, M, Pearce, CL, Kelemen, LE, Goodman, MT, Bandera, EV, Terry, KL, Schoof, N, Eng, KH, Clay, A, Singh, PK, Joseph, JM, Aben, KKH, Anton-Culver, H, Antonenkova, N, Baker, H, Bean, Y, Beckmann, MW, Bisogna, M, Bjorge, L, Bogdanova, N, Brinton, LA, Brooks-Wilson, A, Bruinsma, F, Butzow, R, Campbell, IG, Carty, K, Cook, LS, Cramer, DW, Cybulski, C, Dansonka-Mieszkowska, A, Dennis, J, Despierre, E, Dicks, E, Doherty, JA, Leminen, A , Nevanlinna, H , Pelttari, LM & Australian Ovarian Canc Study Grp 2016, 'Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer', Oncotarget, vol. 7, no. 43, pp. 69097-69110. https://doi.org/10.18632/oncotarget.10215

TY - JOUR

T1 - Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

AU - Hampras, Shalaka S.

AU - Sucheston-Campbell, Lara E.

AU - Cannioto, Rikki

AU - Chang-Claude, Jenny

AU - Modugno, Francesmary

AU - Doerk, Thilo

AU - Hillemanns, Peter

AU - Preus, Leah

AU - Knutson, Keith L.

AU - Wallace, Paul K.

AU - Hong, Chi-Chen

AU - Friel, Grace

AU - Davis, Warren

AU - Nesline, Mary

AU - Pearce, Celeste L.

AU - Kelemen, Linda E.

AU - Goodman, Marc T.

AU - Bandera, Elisa V.

AU - Terry, Kathryn L.

AU - Schoof, Nils

AU - Eng, Kevin H.

AU - Clay, Alyssa

AU - Singh, Prashant K.

AU - Joseph, Janine M.

AU - Aben, Katja K. H.

AU - Anton-Culver, Hoda

AU - Antonenkova, Natalia

AU - Baker, Helen

AU - Bean, Yukie

AU - Beckmann, Matthias W.

AU - Bisogna, Maria

AU - Bjorge, Line

AU - Bogdanova, Natalia

AU - Brinton, Louise A.

AU - Brooks-Wilson, Angela

AU - Bruinsma, Fiona

AU - Butzow, Ralf

AU - Campbell, Ian G.

AU - Carty, Karen

AU - Cook, Linda S.

AU - Cramer, Daniel W.

AU - Cybulski, Cezary

AU - Dansonka-Mieszkowska, Agnieszka

AU - Dennis, Joe

AU - Despierre, Evelyn

AU - Dicks, Ed

AU - Doherty, Jennifer A.

AU - Leminen, Arto

AU - Nevanlinna, Heli

AU - Pelttari, Liisa M.

AU - Australian Ovarian Canc Study Grp

PY - 2016/10/25

Y1 - 2016/10/25

KW - ovarian cancer

KW - immunosuppression

KW - biomarkers

KW - genetic variation

KW - TGFBR2

KW - REGULATORY T-CELLS

KW - FC-GAMMA-RIIB

KW - PERIPHERAL-BLOOD

KW - BREAST-CANCER

KW - DENDRITIC CELLS

KW - LUNG-CANCER

KW - RECEPTOR

KW - STAGE

KW - EXPRESSION

KW - CARCINOMA

KW - 3122 Cancers

KW - 3123 Gynaecology and paediatrics

U2 - 10.18632/oncotarget.10215

DO - 10.18632/oncotarget.10215

M3 - Article

SN - 1949-2553

VL - 7

SP - 69097

EP - 69110

JO - Oncotarget

JF - Oncotarget

IS - 43

ER -